Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2017

October 2017 | 126 pages | ID: GF7F00491BFWEN
QYResearch

Abstracts

In this report, the global Radiopharmaceuticals in Nuclear Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Radiopharmaceuticals in Nuclear Medicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Bracco Imaging S.P.A.
• Cambridge Isotope Laboratories, Inc.
• Cardinal Health, Inc.
• Covidien, Plc
• Eczacibasi-Monrol
• Fujifilm Holdings Corporation
• GE Healthcare (Subsidiary Of General Electric Company)
• IBA Group
• Isotec, Inc. (Sigma-Aldrich)
• Lantheus Medical Imaging, Inc.
• Nordion, Inc.
• Ntp Radioisotopes (Pty), Ltd.
• Siemens Healthcare (Subsidiary Of Siemens AG)
• Taiyo Nippon Sanso Corporation
• Urenco Limited
• Rotem Industries, Ltd., Inc.
• Australian Nuclear Association And Technology Organization (ANSTO)
• Board of Radiation And Isotope Technology (BRIT)
• Institute of Atomic Energy Polatom Radioisotope Centre
• Institute of Isotopes Co., Ltd.
• Institute Of Radioelement (IRE)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Diagnostic Radiopharmaceuticals
• Therapy Radiopharmaceuticals
• Enriched Stable Isotopes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for each application, including

• Diagnostic Application
• Therapeutic Application
• Research
• Pharmaceutical
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2017

1 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET OVERVIEW

1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine
1.2 Radiopharmaceuticals in Nuclear Medicine Segment by Type (Product Category)
  1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Type (Product Category) in 2016
  1.2.3 Diagnostic Radiopharmaceuticals
  1.2.4 Therapy Radiopharmaceuticals
  1.2.5 Enriched Stable Isotopes
1.3 Global Radiopharmaceuticals in Nuclear Medicine Segment by Application
  1.3.1 Radiopharmaceuticals in Nuclear Medicine Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Diagnostic Application
  1.3.3 Therapeutic Application
  1.3.4 Research
  1.3.5 Pharmaceutical
  1.3.6 Other
1.4 Global Radiopharmaceuticals in Nuclear Medicine Market by Region (2012-2022)
  1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Radiopharmaceuticals in Nuclear Medicine (2012-2022)
  1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue Status and Outlook (2012-2022)
  1.5.2 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET COMPETITION BY MANUFACTURERS

2.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Production and Share by Manufacturers (2012-2017)
2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Share by Manufacturers (2012-2017)
2.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation and Trends
  2.5.1 Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate
  2.5.2 Radiopharmaceuticals in Nuclear Medicine Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity and Market Share by Region (2012-2017)
3.2 Global Radiopharmaceuticals in Nuclear Medicine Production and Market Share by Region (2012-2017)
3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption by Region (2012-2017)
4.2 North America Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export, Import (2012-2017)
4.3 Europe Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export, Import (2012-2017)
4.4 China Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export, Import (2012-2017)
4.5 Japan Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export, Import (2012-2017)
4.7 India Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export, Import (2012-2017)

5 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Radiopharmaceuticals in Nuclear Medicine Production and Market Share by Type (2012-2017)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2012-2017)
5.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2012-2017)
5.4 Global Radiopharmaceuticals in Nuclear Medicine Production Growth by Type (2012-2017)

6 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION

6.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Application (2012-2017)
6.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MANUFACTURERS PROFILES/ANALYSIS

7.1 Bracco Imaging S.P.A.
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Cambridge Isotope Laboratories, Inc.
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Cardinal Health, Inc.
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Covidien, Plc
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Eczacibasi-Monrol
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Fujifilm Holdings Corporation
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 GE Healthcare (Subsidiary Of General Electric Company)
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 IBA Group
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Isotec, Inc. (Sigma-Aldrich)
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Lantheus Medical Imaging, Inc.
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Nordion, Inc.
7.12 Ntp Radioisotopes (Pty), Ltd.
7.13 Siemens Healthcare (Subsidiary Of Siemens AG)
7.14 Taiyo Nippon Sanso Corporation
7.15 Urenco Limited
7.16 Rotem Industries, Ltd., Inc.
7.17 Australian Nuclear Association And Technology Organization (ANSTO)
7.18 Board of Radiation And Isotope Technology (BRIT)
7.19 Institute of Atomic Energy Polatom Radioisotope Centre
7.20 Institute of Isotopes Co., Ltd.
7.21 Institute Of Radioelement (IRE)

8 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MANUFACTURING COST ANALYSIS

8.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET FORECAST (2017-2022)

12.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Radiopharmaceuticals in Nuclear Medicine Price and Trend Forecast (2017-2022)
12.2 Global Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Radiopharmaceuticals in Nuclear Medicine
Figure Global Radiopharmaceuticals in Nuclear Medicine Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Diagnostic Radiopharmaceuticals
Table Major Manufacturers of Diagnostic Radiopharmaceuticals
Figure Product Picture of Therapy Radiopharmaceuticals
Table Major Manufacturers of Therapy Radiopharmaceuticals
Figure Product Picture of Enriched Stable Isotopes
Table Major Manufacturers of Enriched Stable Isotopes
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption (K Units) by Applications (2012-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Applications in 2016
Figure Diagnostic Application Examples
Table Key Downstream Customer in Diagnostic Application
Figure Therapeutic Application Examples
Table Key Downstream Customer in Therapeutic Application
Figure Research Examples
Table Key Downstream Customer in Research
Figure Pharmaceutical Examples
Table Key Downstream Customer in Pharmaceutical
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Major Players Product Capacity (K Units) (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity (K Units) of Key Manufacturers in 2016
Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity (K Units) of Key Manufacturers in 2017
Figure Global Radiopharmaceuticals in Nuclear Medicine Major Players Product Production (K Units) (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Production (K Units) of Key Manufacturers (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Share by Manufacturers (2012-2017)
Figure 2016 Radiopharmaceuticals in Nuclear Medicine Production Share by Manufacturers
Figure 2017 Radiopharmaceuticals in Nuclear Medicine Production Share by Manufacturers
Figure Global Radiopharmaceuticals in Nuclear Medicine Major Players Product Revenue (Million USD) (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers
Table 2017 Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers
Table Global Market Radiopharmaceuticals in Nuclear Medicine Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Radiopharmaceuticals in Nuclear Medicine Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution and Sales Area
Table Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Category
Figure Radiopharmaceuticals in Nuclear Medicine Market Share of Top 3 Manufacturers
Figure Radiopharmaceuticals in Nuclear Medicine Market Share of Top 5 Manufacturers
Table Global Radiopharmaceuticals in Nuclear Medicine Capacity (K Units) by Region (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity Market Share by Region (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity Market Share by Region (2012-2017)
Figure 2016 Global Radiopharmaceuticals in Nuclear Medicine Capacity Market Share by Region
Table Global Radiopharmaceuticals in Nuclear Medicine Production by Region (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production (K Units) by Region (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Region (2012-2017)
Figure 2016 Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Region
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Region (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2012-2017)
Table 2016 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region
Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption (K Units) Market by Region (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Region (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Region (2012-2017)
Figure 2016 Global Radiopharmaceuticals in Nuclear Medicine Consumption (K Units) Market Share by Region
Table North America Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Production (K Units) by Type (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Share by Type (2012-2017)
Figure Production Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2012-2017)
Figure 2016 Production Market Share of Radiopharmaceuticals in Nuclear Medicine by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Type (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Radiopharmaceuticals in Nuclear Medicine by Type (2012-2017)
Figure 2016 Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) by Type (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Growth by Type (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption (K Units) by Application (2012-2017)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Applications (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application in 2016
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate by Application (2012-2017)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate by Application (2012-2017)
Table Bracco Imaging S.P.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production Market Share (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (2012-2017)
Table Cambridge Isotope Laboratories, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production Market Share (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (2012-2017)
Table Cardinal Health, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production Market Share (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (2012-2017)
Table Covidien, Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production Market Share (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (2012-2017)
Table Eczacibasi-Monrol Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production Market Share (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (2012-2017)
Table Fujifilm Holdings Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production Market Share (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (2012-2017)
Table GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production Market Share (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (2012-2017)
Table IBA Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Production Market Share (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (2012-2017)
Table Isotec, Inc. (Sigma-Aldrich) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production Market Share (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (2012-2017)
Table Lantheus Medical Imaging, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production Market Share (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medicine
Figure Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
Figure Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
Table Raw Materials Sources of Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
Table Major Buyers of Radiopharmaceuticals in Nuclear Medicine
Table Distributors/Traders List
Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Price (Million USD) and Trend Forecast (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Production (K Units) Forecast by Region (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share Forecast by Region (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share Forecast by Region (2017-2022)
Figure North America Radiopharmaceuticals in Nuclear Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Radiopharmaceuticals in Nuclear Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Radiopharmaceuticals in Nuclear Medicine Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Radiopharmaceuticals in Nuclear Medicine Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Production (K Units) Forecast by Type (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production (K Units) Forecast by Type (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Type (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2017-2022)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source